CareTrust REIT (CTRE) Earnings Date & Reports

Key Takeaways

• CareTrust REIT is expected to report third-quarter 2026 results in early November 2026, for the quarter ending September 30, 2026.
• The company raised its full-year 2026 guidance in August, now projecting normalized FFO (Funds From Operations) of $2.03–$2.06 per share and normalized FAD (Funds Available for Distribution) of $2.01–$2.04 per share.
• Second-quarter 2026 featured a record roughly $900 million of investments at an 8.9% blended yield, bringing year-to-date deployment to about $1.5 billion.
• Investors will be watching external growth pace, U.K. care homes, senior housing (SHOP) expansion, and the $0.39 quarterly dividend.
• The balance sheet remains conservative, with net debt to EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of roughly 1.0x and about $1.4 billion in available liquidity.

Earnings Context and Why It Matters

CareTrust REIT, Inc. is a self-administered real estate investment trust (REIT) that owns and leases skilled nursing, seniors housing, and other healthcare-related properties across the United States and the United Kingdom. The company has delivered back-to-back record investment years, and 2026 is on track to continue that pace. Because a REIT's growth hinges on its ability to acquire properties at attractive yields while protecting operator lease coverage, each quarterly report is a checkpoint on both earnings quality and the durability of the external growth engine. For investors, this print will show whether record investment activity is translating into sustained per-share FFO growth without straining the balance sheet or the dividend.

Earnings Expectations

As a healthcare REIT, CareTrust REIT is most closely evaluated on normalized FFO and FAD per share rather than traditional net income. In the second quarter of 2026, the company reported total revenues of approximately $161.3 million, up about 43% year over year, with normalized FFO and FAD both at $0.51 per share, each up roughly 19% from the prior-year quarter. Management's raised full-year 2026 outlook of $2.03–$2.06 in normalized FFO per share and $2.01–$2.04 in normalized FAD per share now serves as the key benchmark against which third-quarter progress will be measured.

Beyond headline per-share figures, investors are likely to focus on total investment volume, blended stabilized yields, and the mix across skilled nursing, U.K. care homes, SHOP (Senior Housing Operating Portfolio), and loans. The company closed roughly $900 million of investments in the second quarter alone, and any commentary on the size and composition of the current pipeline—reported at approximately $540 million at the end of August—will be central to the reaction. Lease coverage trends and net debt levels also matter, given that they signal the health of both tenants and the capital structure.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to surface trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. For investors following healthcare REITs like CareTrust REIT, it offers a structured way to compare peers and monitor emerging signals as earnings season unfolds.

Market Reaction and Investor Sentiment

Sentiment heading into the third-quarter report has been broadly positive, reflecting two consecutive record years of investment activity and a guidance raise in August. The stock has benefited from strong external growth across skilled nursing, U.K. care homes, and the newer SHOP platform, supported by a balance sheet with low leverage and ample liquidity. At the same time, investors remain attentive to competitive pressures and compressing cap rates in senior housing, which can make it harder to deploy capital at historically attractive yields. The third-quarter print will be judged largely on whether deployment momentum, per-share FFO growth, and lease coverage all remain intact.

Forward Outlook and Key Factors to Monitor

Looking ahead, the key question is whether CareTrust REIT can sustain its investment cadence while preserving earnings quality. Management has signaled that all three growth engines—U.S. skilled nursing, U.K. care homes, and SHOP—are producing, but the composition of future deals will shape both yield and risk. A heavier tilt toward SHOP adds operating exposure, while skilled nursing and triple-net assets tend to carry more predictable rent streams.

Capital access is another factor to watch. The company has relied on equity forward contracts and an at-the-market (ATM) program to fund acquisitions, so changes in share price or broader equity-market conditions could influence the pace of future deployment. Investors will also monitor net debt to EBITDA, which remains well below the company's target range, and the stability of lease coverage across operators.

Finally, the dividend remains a focal point. The quarterly payout was raised to $0.39 per share, and the payout ratio of roughly 76% of normalized FFO leaves room for both reinvestment and potential future increases, provided per-share earnings growth continues. None of this constitutes a price prediction, but these metrics will shape how investors interpret the next several quarters of results.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations